01 1Zhejiang Starry Pharmaceutical Co., Ltd
01 1IOPAMIDOL USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-09-08
Pay. Date : 2022-07-27
DMF Number : 36683
Submission : 2022-01-24
Status : Active
Type : II
20
Zhejiang Starry Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IOPAMIDOL USP, with a corresponding US DMF Number 36683.
Remarkably, this DMF maintains an Active status since its submission on January 24, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 08, 2022, and payment made on July 27, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
